DataMeds AI Quantifies Massive Dilution: Existing Holders Could Be Cut to 5.3%

summarizeSummary

DataMeds AI's information statement reveals that existing stockholders could be diluted down to as little as 5.3% ownership after the May 2026 convertible notes convert and warrants are exercised. The Series A Preferred Stock carries a 10% compounding dividend and a variable conversion price that increases dilution as the stock falls.

check_boxKey Events · Financing and Capital Events · MEDS

• Massive Dilution Quantified

  Existing stockholders would retain only 5.3% to 19.4% of outstanding shares after full conversion of the $21.1M May 2026 Notes and exercise of all PIPE and PA Warrants, depending on the assumed conversion price.

• Death-Spiral Conversion Structure

  The conversion price is the lesser of $6.00 or the prior day's closing price, with a $1.00 floor that resets to 20% of the closing price on the Mandatory Conversion Date. As the stock falls, more shares are issued, creating downward pressure.

• Compounding 10% Preferred Dividend

  Series A Preferred Stock accrues a 10% annual dividend on its $1,000 stated value beginning six months after issuance, compounding monthly and increasing the number of common shares issuable upon conversion over time.

• Warrant Overhang Adds to Dilution

  PIPE Warrants for 8.3M shares at $7.50 and PA Warrants for 1.4M shares at $4.275, with the PA Warrants adjusting to 12% of total conversion and exercise shares, further dilute existing holders.

auto_awesomeAnalysis · MEDS · Trade & Services

This information statement lays out the full mechanics of the May 2026 convertible note financing and its conversion into Series A Preferred Stock. The dilution tables show existing stockholders would retain only 5.3% to 19.4% of the company after full conversion and warrant exercise, depending on the conversion price. At the current $3.10 share price, the conversion price would be near the lower end of the range, meaning existing holders face severe dilution. The Series A Preferred Stock carries a 10% annual dividend that compounds into the stated value, increasing future dilution over time. This is a death-spiral-style structure: as the stock price falls, more shares are issued, which pressures the price further. The filing also confirms the election of five directors and ratification of Suri & Co. as auditor, but the dilution mechanics are the dominant story.